Skip to content

Immunocore vs Tmunity Therapeutics

Immunocore logo

Immunocore

Science to Transform Lives

607 employees · est. 2008 · Abingdon, United Kingdom

VS
Tmunity Therapeutics logo

Tmunity Therapeutics

Pioneering the future of immunotherapy through innovative T cell engineering to tackle a diverse array of diseases

12 employees · est. 2015

Immunocore is the older company (2008 vs 2015); Immunocore is the larger of the two.

Side-by-Side Comparison

Immunocore Tmunity Therapeutics
Founded
2008 older 2015
Headquarters
Abingdon, United Kingdom Not tracked yet
Employees
607 larger 12
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
IPO Acquired
Total Funding
$975.60M $220.00M
Funding Rounds
10 6
Services
Development of TCR therapies, Clinical trials management, Research in immunotherapy, Therapeutic pipeline development Not tracked yet
Target Customers
Patients with cancer, Patients with infectious diseases, Patients with autoimmune diseases, Healthcare professionals Not tracked yet
Taxonomy
T Cell ReceptorImmunotherapyCancer TherapyOncologyMetastatic MelanomaInfectious Diseases +8 ImmunotherapyT Cell EngineeringT Cell Receptor (TCR)Regulatory T Cells (Treg)Universal Engineered T CellsGenetically Engineered T Cells +9
Website
immunocore.com tmunity.com
Immunocore logo

About Immunocore

Immunocore, founded in 2008 and headquartered in the United Kingdom, is a prominent player in the Biotechnology, Health Care, and Pharmaceutical industries. The company's slogan, "Science to Transform Lives," encapsulates its mission to develop groundbreaking T cell receptor (TCR) biological therapi...

Tmunity Therapeutics logo

About Tmunity Therapeutics

Tmunity Therapeutics, founded in 2015, is at the forefront of biotech innovation, striving to reshape the landscape of immunotherapy through its pioneering work in T cell engineering. The company emphasizes T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered...

Also comparing in this category

Comparing more than these two?

Get Immunocore, Tmunity Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Immunocore compare?

A PDF of Immunocore and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Immunocore was founded in 2008, based in Abingdon, United Kingdom, with 607 employees. Immunocore, founded in 2008 and headquartered in the United Kingdom, is a prominent player in the Biotechnology, Health Care, and Pharmaceutical industries. The company's slogan, "Science to Transform. Tmunity Therapeutics was founded in 2015, with 12 employees. Tmunity Therapeutics, founded in 2015, is at the forefront of biotech innovation, striving to reshape the landscape of immunotherapy through its pioneering work in T cell engineering. The company emph.
Immunocore has raised $975.60M and Tmunity Therapeutics $220.00M. Latest stage: Immunocore IPO, Tmunity Therapeutics Acquired.
Both work in Biotechnology and Health Care and list immunotherapy, oncology and infectious diseases among their focus areas.

Compare Immunocore with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Immunocore on 22 Jun 2026, and Tmunity Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout